Home |  Contact Us | Site Map

Investor Relations

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.

Recent Releases

Oct 8, 2014
RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014

Oct 7, 2014
BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress

View all releases »

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations
919.859.7910
investorrelations@biocryst.com

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)

Stock Information
NASDAQ : BCRX
$11.83   - 0.36
Oct 24, 2014
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.